
|Articles|December 4, 2015
Orphan Drug Market to Grow at Over 10% CAGR to 2019
December 04, 2015.
Advertisement
Research and Markets released its report Global Orphan Drugs Market 2015-2019, forecasting the market to grow at a CAGR of 10.05% over the period 2014-2019.
Research analysts noted emerging trends in the orphan drug market are a focus on biologics, shorter drug development timelines, and the challenges of enrollment. Conducting clinical trials in rare diseases with smaller number of patients available for clinical studies is around recruiting enough patients to generate significant comparative data.
Read the full
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It
2
FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer
3
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301
4
FDA Sends CRL to Cingulate for CTx-1301
5




